Molinaro A, Braadland PR, Carpino G, Carreras A, Nikolaidis M, Hanzely P, Beck KR, Ali AH, Bossen L, Frank A, Lundqvist A, Juran BD, Overi D, Geng L, Amundsen-Isaksen E, Reims HM, Björk I, Grzyb K, Abildgaard A, Folseraas T, Cornillet M, Helgadóttir H, McCauley BM, Cristoferi L, Carbone M, Cardinale V, Høivik ML, Engesæter LK, Tjønnfjord SKV, McCann Aet al.(2026) Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling Nat Metab(in press) DOI 10.1038/s42255-026-01600-1, PubMed 42698000
Breder S, Wang B, Villard C, Båve A, Lindström-Älgå L, Eide E, Engesæter LK, Reims HM, Grzyb K, Aabakken L, Melum E, Line PD, Wiencke K, Folseraas T, Bergquist A(2026) Liver transplantation in primary sclerosing cholangitis with hepatobiliary neoplasia: survival outcomes and impact of diagnostic uncertainty Scand J Gastroenterol, 1-12(in press) DOI 10.1080/00365521.2026.2709611, PubMed 42549941
Peisl S, Melum E(2026) From Kimchi to Primary Sclerosing Cholangitis: Leuconostoc citreum LB-P8 as a Microbiome-Based Therapeutic Approach Cell Mol Gastroenterol Hepatol, 20(8), 101800 DOI 10.1016/j.jcmgh.2026.101800, PubMed 42097543
